University Hospital Basel, Phase 1 Research Unit
Basel, Switzerland
NCT Number: NCT02563847
With this study the investigators investigate the effects of amino acids (tryptophan in two different concentrations, leucin) and sugar alcohols (xylitol, erythritol) on satiety mechanisms.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Basel, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of glucose
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of insulin are measured
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of glucagon are measured
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of glucagon-like Peptide (GLP-1) are measured
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of PYY are measured
Time frame: changes from baseline to three hours after treatment
Plasma concentrations of cholecystokinin are measured
Time frame: changes from baseline to four hours after treatment
measured by C13 breath test
University Hospital, Basel, Switzerland
Other
Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Normal Weight and Obese Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716579
Brain Diseases, Brain Neoplasms
Ljubljana, Slovenia
View Trial DetailsNCT05171855
Adult Growth Hormone Deficiency, Bone Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT02781727
Bone Diseases, Bone Diseases, Developmental
Birmingham, Alabama, United States
View Trial Details